Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Contextualized perceptions of movement as a source of expanded insight: People with multiple sclerosis' experience with physiotherapy.
Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes.
Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
Self-rating makes the difference: Identifying palliative care needs of patients feeling severely affected by multiple sclerosis.
Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica.
Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.
Pregnancy, sex and hormonal factors in multiple sclerosis.
Functional brain networks: Linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG Study.
Brain-derived neurotrophic factor deficiency restricts proliferation of oligodendrocyte progenitors following cuprizone-induced demyelination.
Peginterferon beta-1a (Plegridy) for multiple sclerosis.
Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage.
Cost-effectiveness of multiple sclerosis disease-modifying therapies: a systematic review of the literature.
Coexistence of peripheral myelin protein 22 and dystrophin mutations in a Chinese boy.
[A retrospective study of patients with early onset of multiple sclerosis in Omskaya Oblast.]
Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
Therapeutics to Promote CNS Repair: A Natural Human Neuron-Binding IgM Regulates Membrane-Raft Dynamics and Improves Motility in a Mouse Model of Multiple Sclerosis.
Variations of the UNC13D Gene in Patients with Autoimmune Lymphoproliferative Syndrome.
Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis.
Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
Neuromyelitis optica in child: diagnostic and therapeutic challenges.
BRBN-T validation: adaptation of the Selective Reminding Test and Word List Generation.
Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain.
Partial acute transverse myelitis is a predictor of multiple sclerosis in children.
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis.
Pages
« first
‹ previous
…
342
343
344
345
346
347
348
349
350
…
next ›
last »